MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
BGLC — BioNexus Gene Lab Corp Common stock
NasdaqBioNexus Gene Lab Corp Common stock
$1.27
+0.07(+5.83%)
- O
- 1.25
- H
- 1.28
- L
- 1.25
- V
- 2.53K
⏱️ End-of-day dataAs of Oct 2, 2026
BGLC — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash | $1.34M | $2.38M | $1.15M | 814,179.00 | $1.09M | $1.58M |
| Cash Equivalents | $2.63M | $1.66M | N/A | N/A | $2.50M | $2.79M |
| Cash And Cash Equivalents | $3.96M | $4.04M | $1.15M | 814,179.00 | $3.60M | $4.38M |
| Accounts Receivable | 79,860.00 | 505,885.00 | $1.52M | $1.85M | $1.44M | $1.38M |
| Other Receivables | 88,983.00 | 81,728.00 | 98,903.00 | 151,269.00 | 235,727.00 | 203,660.00 |
| Inventory | 667,154.00 | 676,703.00 | $1.01M | $1.22M | $1.18M | $1.39M |
| Other Current Assets | 333,332.00 | 83,333.00 | N/A | N/A | N/A | N/A |
| Total Current Assets | $5.20M | $5.45M | $5.63M | $6.38M | $6.54M | $7.43M |
| Properties | $2.23M | $2.17M | $2.12M | $2.13M | $2.05M | $2.04M |
| Machinery Furniture Equipment | 520,624.00 | 520,299.00 | 518,917.00 | 518,917.00 | 497,603.00 | 493,856.00 |
| Accumulated Depreciation | -937,315.00 | -909,022.00 | -880,592.00 | -851,591.00 | -823,791.00 | -797,149.00 |
| Investments And Advances | $2.03M | $2.03M | 237,760.00 | $1.25M | $1.21M | $1.27M |
| Total Non Current Assets | $3.84M | $3.80M | $1.99M | $3.04M | $2.94M | $3.00M |
| Total Assets | $9.04M | $9.25M | $7.62M | $9.42M | $9.48M | $10.43M |
| Accounts Payable | 2,137.00 | 2,335.00 | 184,600.00 | $1.37M | $1.18M | $1.50M |
| Accrued Expenses | 108,552.00 | N/A | N/A | N/A | N/A | N/A |
| Short Term Debt | 66,021.00 | 59,147.00 | 56,803.00 | 55,809.00 | 52,173.00 | 50,816.00 |
| Deferred Revenue | 8,416.00 | 8,385.00 | 11,264.00 | 11,348.00 | 21,964.00 | 95,879.00 |
| Total Current Liabilities | 796,470.00 | 520,957.00 | 678,023.00 | $1.76M | $1.56M | $1.95M |
| Long Term Debt | 150,407.00 | 116,899.00 | 126,943.00 | 141,347.00 | 147,940.00 | 159,741.00 |
| Total Non Current Liabilities | 150,407.00 | 116,899.00 | 126,943.00 | 141,347.00 | 147,940.00 | 159,741.00 |
| Total Liabilities | 946,877.00 | 637,856.00 | 804,966.00 | $1.90M | $1.71M | $2.11M |
| Common Stock | $20.17M | $20.17M | $17.33M | $17.33M | $17.33M | $17.33M |
| Retained Earnings | $-6.97M | $-6.43M | $-5.39M | $-4.68M | $-4.07M | $-3.44M |
| Other Shareholders Equity | -98,849.00 | -120,749.00 | -112,547.00 | -115,763.00 | -482,841.00 | -555,000.00 |
| Total Shareholders Equity | $8.09M | $8.61M | $6.82M | $7.52M | $7.77M | $8.32M |
| Additional Paid In Capital | $-5.01M | $-5.01M | $-5.01M | $-5.01M | $-5.01M | $-5.01M |
| Other Short Term Investments | N/A | N/A | $1.74M | $2.24M | N/A | N/A |
| Deferred Liabilities | N/A | N/A | 0.00 | 0.00 | 0.00 | 0.00 |
| Construction In Progress | N/A | N/A | N/A | N/A | N/A | 0.00 |